186 related articles for article (PubMed ID: 7285008)
1. Surface membrane antigens of hemopoietic tumor cell lines and normal marrow progenitor cells.
Hasthorpe S; Rogerson J; McKenzie IF
Cancer Res; 1981 Oct; 41(10):3985-91. PubMed ID: 7285008
[TBL] [Abstract][Full Text] [Related]
2. Identification of a tumor cell-derived differentiation antigen on mouse colony-forming units in the spleen and progenitor cells.
Hasthorpe S; Stokes K; Rogerson J
Cancer Res; 1985 Oct; 45(10):5042-9. PubMed ID: 4027983
[TBL] [Abstract][Full Text] [Related]
3. Expression of tumor-associated surface membrane antigens on marrow CFU-s, CFC-gm, BFU-e, and brain CFU-s.
Hasthorpe S; Bartlett PF; Rogerson J
Int J Cell Cloning; 1985 Jan; 3(1):10-21. PubMed ID: 3973426
[TBL] [Abstract][Full Text] [Related]
4. Surface antigens of murine hemopoietic stem cells. I. Cross reactivity of antisera against differentiated hemopoietic cells with bone marrow stem cells.
Berridge MV; Okech N
Exp Hematol; 1979 Oct; 7(9):452-68. PubMed ID: 527692
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated surface membrane antigens on CFUs: characterization using the fluorescent activated cell sorter.
Hasthorpe S; Rogerson J
Exp Hematol; 1982 Jan; 10(1):9-19. PubMed ID: 7060662
[TBL] [Abstract][Full Text] [Related]
6. BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice.
McNagny KM; Cazenave PA; Cooper MD
J Immunol; 1988 Oct; 141(8):2551-6. PubMed ID: 3262662
[TBL] [Abstract][Full Text] [Related]
7. Binding of monoclonal antibodies that inhibit spleen colony formation to leukemic cell lines.
Ralph SJ; McCaffery P; Tan AS; Berridge MV
Cancer Res; 1984 Sep; 44(9):3825-30. PubMed ID: 6744299
[TBL] [Abstract][Full Text] [Related]
8. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of Qa-m2 alloantigen on murine hemopoietic progenitor cells. Selective enrichment for megakaryocyte progenitors.
Harris RA; Hogarth PM; McKenzie IF; Penington DG
Exp Hematol; 1983 Jul; 11(6):527-41. PubMed ID: 6617788
[TBL] [Abstract][Full Text] [Related]
10. Variable expression of Qa-m7, Qa-m8, and Qa-m9 antigenic determinants on primitive hemopoietic precursor cells.
Harris RA; Sandrin MS; Sutton VR; Hogarth PM; McKenzie IF; Penington DG
J Cell Physiol; 1985 Jun; 123(3):451-8. PubMed ID: 2580849
[TBL] [Abstract][Full Text] [Related]
11. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
Dowding CR; Gordon MY; Goldman JM
Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
[TBL] [Abstract][Full Text] [Related]
12. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
14. Thy-1 antigen in murine hematopoietic progenitor differentiation.
Miller BA; Lipton JM
Prog Clin Biol Res; 1983; 134():389-97. PubMed ID: 6141570
[TBL] [Abstract][Full Text] [Related]
15. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
16. Identification of cell surface antigens present on murine hematopoietic stem cells.
Miller BA; Antognetti G; Springer TA
J Immunol; 1985 May; 134(5):3286-90. PubMed ID: 3980993
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
18. Mouse bone marrow stromal cell line MC3T3-G2/PA6 with hematopoietic-supporting activity expresses high levels of stem cell antigen Sca-1.
Satoh M; Mioh H; Shiotsu Y; Ogawa Y; Tamaoki T
Exp Hematol; 1997 Aug; 25(9):972-9. PubMed ID: 9257811
[TBL] [Abstract][Full Text] [Related]
19. MBM-1, a differentiation marker of mouse hemopoietic cells defined by a rat monoclonal antibody.
Davis JM; Kubler AM; Conscience JF
Exp Hematol; 1983 Apr; 11(4):332-40. PubMed ID: 6840228
[TBL] [Abstract][Full Text] [Related]
20. Onset of expression of the components of the Kell blood group complex.
Pu JJ; Redman CM; Visser JW; Lee S
Transfusion; 2005 Jun; 45(6):969-74. PubMed ID: 15934996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
